Changes in Beneficial Ownership · 4
Immunovant, Inc.
IMVTNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1787948868.xml
Filing details
- Report period
- 2026-08-28
- Issuer
- Immunovant, Inc.
- Issuer CIK
- 0001764013
- Trading symbol
- IMVT
- Rule 10b5-1 indication
- Checked
Reporting owner 1
- Name
- Pande Atul
- Reporting owner CIK
- 0001643071
- Relationship
- Director
- Address
- C/O IMMUNOVANT, INC., 1000 PARK FORTY PLAZA, SUITE 210, DURHAM, NC, 27713
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-08-28 | M · Form 4[F1] | 1,500 | A | 8.43 | 118,231 | D |
| Common Stock | 2026-08-28 | S · Form 4[F1] | 1,500 | D | 43.27 | 116,731 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- A
- Acquired
- D
- Direct
- S · Form 4
- Sale on the market or privately
Non-derivative holdings
| Security | Amount owned | Ownership | Nature of ownership |
|---|---|---|---|
| Common Stock | 20,000 | I | By Trust |
Table key
- I
- Indirect
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | 8.43 | 2026-08-28 | M · Form 4[F1] | 1,500 | D | 0 | [F2] | 2029-11-19 | Common Stock | 1,500 | 65,181 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- D
- Direct
Footnotes
Signature 1
- Signed
- /s/ Tiago Girao, attorney-in-fact for Atul Pande
- Date
- 2026-08-28